A randomized, open-label, com- parative, crossover trial on preference, efficacy, and safety profiles of lispro insulin U-100 versus concentrated lispro insulin U-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treat- ment adherence - Gentile, S; Fusco, A; Colarusso, S (Expert Opin Drug Saf, 2018)
et al.